Advertisement
Australia markets closed

  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     

  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     

  • AUD/USD

    0.6543
    +0.0019 (+0.30%)
     

  • OIL

    84.05
    +0.48 (+0.57%)
     

  • GOLD

    2,355.20
    +12.70 (+0.54%)
     

  • Bitcoin AUD

    98,326.99
    +537.62 (+0.55%)
     

  • CMC Crypto 200

    1,390.72
    -5.82 (-0.42%)
     

  • AUD/EUR

    0.6096
    +0.0023 (+0.37%)
     

  • AUD/NZD

    1.0976
    +0.0019 (+0.17%)
     

  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     

  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     

  • FTSE

    8,122.66
    +43.80 (+0.54%)
     

  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     

  • DAX

    18,012.65
    +95.37 (+0.53%)
     

  • Hang Seng

    17,639.69
    +355.15 (+2.05%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

Stock market today: 4 tickers trending on Yahoo Finance

Dani Romero
·Reporter
Updated ·2-min read

Stock futures are lower as investors await this week's Federal Reserve monetary policy meeting.

Here are 4 tickers trending on Yahoo Finance in premarket trading:

Bitcoin USD (BTC-USD): Bitcoin fell below $19,000 on Monday morning as risky assets sold off ahead of a wave of monetary tightening that’s set to stretch from Europe to the U.S. this week. The largest digital token dropped as much as 7.8% and was trading at $18,741.50 as of 7:00 a.m. in New York. Investors are bracing for volatility in anticipation of the Federal Reserve’s interest-rate hike expected on Wednesday.

bluebird bio, Inc. (BLUE): Shares of bluebird bio Inc. were higher by more than 9% in premarket trading Monday after the Food and Drug Administration (FDA) approved a personalized gene therapy for an ultra-rare childhood brain disease, called cerebral adrenoleukodystrophy or CALD. The therapy is built from a patient’s own stem cells and will be the first to be made available in the U.S. This is the second clearance from the FDA for bluebird bio in the last four weeks, following another gene therapy for the blood disorder beta thalassemia.

Ethereum USD (ETH-USD): Ethereum price tumbled to its lowest level since late July. The second largest cryptocurrency by market capitalization dipped below $1,300, continuing its post-Merge dip. Last week, Ethereum moved to a more energy efficient proof-of-stake method for securing the network. Since then, Ethereum has lost more than 20% of its value, with its market cap now standing at around $159 billion.

Coinbase Global, Inc. (COIN): Shares of Coinbase were lower Monday in pre-market trading following President Biden’s released framework Friday morning on crypto regulation. President Biden is encouraging regulators to "aggressively pursue" investigations and enforcement against illegal actions in digital assets.

Dani Romero is a reporter for Yahoo Finance. Follow her on Twitter @daniromerotv

ADVERTISEMENT

Click here for the latest stock market news and in-depth analysis, including events that move stocks

Read the latest financial and business news from Yahoo Finance

Download the Yahoo Finance app for Apple or Android

Follow Yahoo Finance on Twitter, Facebook, Instagram, Flipboard, LinkedIn, and YouTube